Page History
...
Item | Who | Notes |
---|---|---|
Integrating environmental exposures of human cancer patients with canines | Matthew Breen |
|
Cellular Data (Flow Cytometry, Nano String Data) | Michael Olin |
|
Workshop for Immuno-Oncolgy (IO) Data Analytics | Erika Kim |
|
Non-Cancer Diseases | Toby Hecht | |
Pharma-specific Focus Group or Interviews | Amy Leblanc |
|
...
Amy - I think Debbie Knapp has this data showing a transcriptional shift in BRAF-mutant bladder cancer
Toby - There has been a suggestion to go beyond cancer and involve other institutes particularly if they can help with funding. Also the Dog Aging project that looks at normal dogs until end of life and some of them develop tumors and the NCI is willing to co-fund sequencing on these tumors as they arise, we . We are waiting to hear back from Aging Institute, other thing is investigating environmental exposures in relation to to tumors. Let's derive a list of interesting topictopics.
Warren - Representing Representing the life trajectory of the dogs, attaching the specimens and data derived from those specimens at the appropriate point in that dog's life would be valuable. The pre and post- treatment specimens are one example (genomics, proteomics, microbiome). Let's say we have measurements from when the dog is born vs. end of life, how can we represent that data to better understand the trajectory of their lives and also carcinogenesis if applicable. Can we prepare the ICDC for hosting this type of data?
...
Amy - Friend from Bristol Meyers Squib reached out to better understand relationsips relationships with pharma, maybe we should put together a panel of pharma folks to see if they can have a focus group to determine data and tooling that would be useful to that community.
...